Year: 2022

news_6

Australia $218 Mn Protein Supplement (Protein Powder, Protein Bar, Ready to Drink) Markets, Competition, Forecast & Opportunity, 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Protein Supplement Market, By Product Type (Protein Powder, Protein Bar, Ready to Drink, and Others), By Raw...

news_6

Who’s Who in Asia 2022: Directory of Public and Academic Libraries, International Organizations, Embassies, Businesses, Media, Scientific and Professional Bodies – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Who's Who in Asia 2022" directory has been added to ResearchAndMarkets.com's offering. Who's Who in Asia will be...

news_6

Global Phase 3 Trial of BeiGene’s PD-1 Inhibitor, Tislelizumab, in Combination with Chemotherapy Meets Primary Endpoint in First-Line Advanced Esophageal Squamous Cell Carcinoma

Statistically significant and clinically meaningful improvement in overall survival achieved for tislelizumab and chemotherapy compared to placebo and chemotherapy Safety...